EXECUTIVE HEALTH NEWSLETTER

Document Type: 
Collection: 
Document Number (FOIA) /ESDN (CREST): 
CIA-RDP78-05077A000100090023-9
Release Decision: 
RIPPUB
Original Classification: 
K
Document Page Count: 
4
Document Creation Date: 
December 9, 2016
Document Release Date: 
May 26, 1999
Sequence Number: 
23
Case Number: 
Publication Date: 
April 1, 1972
Content Type: 
REPORT
File: 
AttachmentSize
PDF icon CIA-RDP78-05077A000100090023-9.pdf258.36 KB
Body: 
April 1972 With this first edition, we hope to inaugurate a short newsletter, including points of importance as regards -the Executive Annual Physical Program: health, physical fitness, and general well-being. Editions will come out every two months. In the future, we hope to have short articles on points of importance for the health of our executives. There will be a section including facts of general medical interest. Finally, we hope to inaugurate a question and answer section. Annual Physical Examination. It might be of interest to review what is done in our current executive annual physical examina- tion. Currently, our examinations are done in three stages, and often because of additional studies, will include extra stages. The first stage consists of laboratory screening, which includes visual examination for near and distant vision, a hearing test which measures hear- ing changes in the speech frequencies, and a tono- metric examination which is done to detect early stages of glaucoma (increased pressure within the eye than can be asymptomatic but can lead to visual loss). The laboratory studies include a complete uri- nalysis in which the urine is examined for albumin, sugar, and microscopically for the presence of cells and bacteria. Blood studies are done and include hematocrit, which will detect anemia, a blood test of thyroid function, and then 12 determinations on our SMA 12/60 Autoanalyser. These latter deter- minations are done automatically and results are printed out on a graph form as well as directly typed out. On the next page you will see an example of the type reading the physician receives. The various measurements done on the blood include: 1. Calcium and phosphorus which reflect bone metabolism. 2. Glucose, the determination which will detect diabetes and diabetes. 3. BUN (blood urea of kidney function. of blood sugar early stages of nitrogen) which is 4. Uric acid, which gives a reading on the pos- sibility of gout and may also be altered by certain medicines. 5. Cholesterol readings, which parallel possible arteriosclerosis. 6. Total protein and albumin which reflect the general well-being of the body and detect diseases of the liver and bone marrow. 7. Bilirubin, a reflection of bile pigments in blood which may detect alterations in liver function and also abnormalities in which blood corpuscles are being destroyed too rapidly. Approved For Release 2000/08/29 : CIA-RDP78-05077A000100090023-9 157- 10_-j- 500EE 10 13_7- 127- 500 7 77 200 40 UM 7 50 10 6 5 bgx> 7 r 150 X 4? PI 0~1111\111` Ml~ 200. 100 \c c 7r 7- 21 Approved For Reloa+se 2000/08/29 : CIA-RDP78-05077AOO 0090024-9 0L. 0 1D~_ 8-- 10_= 3507- 600- 300- - Figure 1. Autoanalyser graph 550f- 4 5 0 j- 7 250 3501 200 Approved For Release 2000/08/29 CIA-RDP78-05077A000100090023-9 t 400k- 200t- SGOT/ 340 Ca+"I Inor. Phos. Glu. BUN Uric Acid Choi. T.P. Alb. T. Bili. Phos. LDH 340 mg % mg%P mg % mg% mg% mg% gm% gill,,,. mg% mU.ini mu./ml mu./m. 8. ..4lk pr .@ #tft1ReI wi2OO0/081'2 : CIA-RDR17"5 7AQfWMQQai9ation, the labora- altered by changes in bone metabolism and liver tory studies are available for the physician to . disease. -1-3 9. LDH and SCOT, enzymes which may reflect heart disease, liver disease. review; m a Mon, a chest X-ray has been done and an electrocardiogram has been taken which is now being interpreted by computer. HEALTH TOPICS Factors Favoring Development of Coronary Artery Disease. The risk factors favoring the development of coronary artery disease are recognized to be hyper- tension (high blood pressure), smoking, obesity, increased blood lipids (cholesterol and triglycer- ides ), lack of exercise, elevated blood levels of uric acid, diabetes mellitis, and a family history of coro- nary artery disease. In all cases except the family history, these risk factors can be reversed or re- duced through medical therapy, self-discipline, and changes in habits. Recognition of these risk factors is obvious in some cases and requires medical and laboratory examinations in others. An awareness of these factors and vigorous attempts to reverse them are strongly recommended. Discussions of these risks and other related problems will appear in future newsletters. Impact of Heart Disease in the United States. Coronary artery disease affects over 20 million people in the United States. Each year, more than 600,000 persons die from myocardial infarction, or "heart attack." More than half of these persons die before reaching medical care. The total cost of illness exceeds ten billion dollars each year. Over 50 million man-days of production are lost each year because of coronary atherosclerotic heart disease. Gradually progressive, supervised physical activity programs following heart attacks have been instituted in 1,500 patients at Grady Memorial Hospital in Atlanta, Georgia, and have allowed a more rapid return to normal living. Early ambula- tion has been helpful both psychologically and physiologically in most. It has been estimated that if the duration of hospitalization for each patient with a heart attack could be safely decreased by just one day, in the course of a year, it would reduce the cost of medical care in this country by 400 million dollars. Alcohol May Be Harmful to the Cardiac Patient. A Fordham Hospital group in New York has found that ten heart patients pumped less blood one-half hour after drinking two ounces of 86 proof whiskey compared to- pre-drinking levels. Four non- cardiac patients pumped more blood after alcohol. At Mount Sinai Medical School, muscle deteriora- tion, possibly in the heart also, occurred in three non-alcoholics given a fifth of 86 proof whiskey every day for four weeks. Normalcy was returned on cessation of drinking. It is concluded that in the presence of heart disease, the drinking of alcohol may be hazardous. The Surgeon General's Report on the Effects of Smoking on Non-Smokers. The United States Surgeon General's new report on cigarette smoking reinforces evidence of tobacco links to lung cancer, unsuccessful pregnancy, and coronary heart disease. It also describes the plight of the non-smoker surrounded by tobacco smoke. The burning of a fair amount of tobacco in a con- fined space can clearly push the carbon monoxide concentration to and over the threshold limits set by Federal law for occupational exposure. There is some risk, for example, for a non-smoker driving in a car full of smokers. The levels of carbon mon- oxide exposures are not too different from those that have been associated with "altered hearing, visual acuity loss, and a loss of ability to distinguish bright- ness." At carbon monoxide levels similar to those at an average party, heart disease patients show symptoms of heart muscle oxygen lack. It is clear that the smoker may place at risk not only himself but also those around him. Saccharin Danger Versus Safety. The FDA has removed saccharin from the so- called GRAS (generally recognized as safe) list and has set the safe average adult intake at one gram per day. This amount is the equivalent of about seven 12 ounce bottles of diet soft drink. The 20 test rats which were studied and which in- fluenced that decision received a diet of 5% sac- charin for two years. For man, that would equal 875 bottles of diet cola a day. Three of the 20 rats studied had signs of bladder tumor at the end of the experiment; whether the tumors were cancerous or not has not yet been determined. Approved For Release 2000/08/29 : CIA-RDP78-05077A000100090023-9 ^ C.L% For PQ 8/29: CIA-RDP78-05?7AQKQ,Q~A9 ^ SECRET ROUTING AND RECORD SHEET SUBJECT: (Optional) Efforts in the Prevention of Coronary Artery Disease FROM: EXTENSION NO. Director of Medical Services Room 1D4061 Headquarters 7711 DATE j 3 J 1g72 TO: (Officer designation, room number, and DATE building) OFFICER'S COMMENTS (Number each comment to show from whom RECEIVED FORWARDED INITIALS to whom. Draw a line across column after each comment.) 1Deputy Director forSu R 7D26 port o"\ oom Headquarter ' 3: Returned per our telecon. I believe it essential that we have a 3. Acting Director of Medical revised paper for the Director by Services 1D4061 HQS 1~~Z 27 June 1972. 4. r l { t ~ 5 J0in . Coffey Att: Memo dtd 16 June 72 for DD/S 6. fr D/MS, subj: Efforts in the Prevention of Coronary Artery Disease 7. 8. 10. 11. 12. 13. 14. 15. FOR 3-62 61 0 USEE-PREV DITIO S SECRET 11 CONFIDENTIAL ^ INTERNAL ONLY F-1 UNCLASSIFIED